BPA
SRPT icon

Beacon Pointe Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Beacon Pointe Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,188
Closed -$203K – 1281
2025
Q1 		$203K Buy
3,188
+4
+0.1% +$421 ﹤0.01% 1150
2024
Q4 		$387K Sell
3,184
-8
-0.3% -$980 ﹤0.01% 914
2024
Q3 		$399K Sell
3,192
-808
-20% -$112K ﹤0.01% 927
2024
Q2 		$632K Sell
4,000
-22
-0.5% -$2.83K 0.01% 800
2024
Q1 		$521K Sell
4,022
-2,282
-36% -$280K 0.01% 901
2023
Q4 		$608K Sell
6,304
-463
-7% -$44.4K 0.01% 830
2023
Q3 		$820K Sell
6,767
-348
-5% -$39.3K 0.01% 692
2023
Q2 		$815K Sell
7,115
-338
-5% -$43.6K 0.01% 575
2023
Q1 		$1.03M Sell
7,453
-2,580
-26% -$335K 0.02% 538
2022
Q4 		$1.3M Sell
10,033
-492
-5% -$57K 0.03% 450
2022
Q3 		$1.16M Buy
10,525
+210
+2% +$21.2K 0.03% 430
2022
Q2 		$771K Sell
10,315
-1,893
-16% -$139K 0.02% 535
2022
Q1 		$954K Buy
12,208
+2,605
+27% +$199K 0.01% 636
2021
Q4 		$865K Sell
9,603
-5,540
-37% -$474K 0.02% 404
2021
Q3 		$1.4M Buy
15,143
+12,390
+450% +$954K 0.03% 345
2021
Q2 		$214K Buy
+2,753
New +$209K 0.01% 778

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Beacon Pointe Advisors's SRPT Position: Q2 2025 in Review

Beacon Pointe Advisors sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 3,188 shares — an estimated $203K sold.

Beacon Pointe Advisors first reported a position in SRPT in Q2 2021 and held it in 16 quarters. The position peaked at $1.4M in Q3 2021. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Beacon Pointe Advisors reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Beacon Pointe Advisors sold 3,188 Sarepta Therapeutics shares in Q2 2025, an estimated $203K.
  • Beacon Pointe Advisors first reported a position in Sarepta Therapeutics in Q2 2021 and held it in 16 quarters.
  • Beacon Pointe Advisors's Sarepta Therapeutics position peaked at $1.4M in Q3 2021.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Beacon Pointe Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.